Showing results (241-250 of 1,176) with videos related to
Sort By:
Pageof 118
Cancer Cytopathology|September 9, 2015
Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening?Yonca Kanber, Michele Charbonneau, Manon AugerCancer Cytopathology|October 17, 2014
A cytomorphometric analysis of pulmonary and mediastinal granulomas: differentiating histoplasmosis from sarcoidosis by fine-needle aspirationMichael P Gailey, Matthew E Keeney, Chris S JensenCancer Cytopathology|August 16, 2014
Implications of a suspicious afirma test result in thyroid fine-needle aspiration cytology: an institutional experienceRicardo R Lastra, Michelle R Pramick, Cody J Crammer, et al.Cancer Cytopathology|November 13, 2014
Accuracy and risk of malignancy for diagnostic categories in urine cytology at a large tertiary institutionKaren Chau, Lisa Rosen, Constantinos Coutsouvelis, et al.Cancer Cytopathology|November 20, 2013
Untutored discrimination training on paired cell images influences visual learning in cytopathologyAndrew Evered, Darren Walker, Andrew A Watt, et al.Cancer Cytopathology|November 15, 2013
Targeted next-generation sequencing using fine-needle aspirates from adenocarcinomas of the lungHope E Karnes, Eric J Duncavage, Cory T BernadtCancer Cytopathology|October 19, 2017
Immunocytochemistry for SOX-11 and TFE3 as diagnostic markers for solid pseudopapillary neoplasms of the pancreas in FNA biopsiesWen-Chi Foo, Grant Harrison, Xuefeng ZhangCancer Cytopathology|February 10, 2018
The impact of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on the rate of malignancy for atypia of undetermined significance subcategoriesJen-Fan Hang, William H Westra, Amy G Zhou, et al.Cancer Cytopathology|May 15, 2018
Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsyInga-Marie Schaefer, Jonathan A Fletcher, G Petur Nielsen, et al.Cancer Cytopathology|May 13, 2017
Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screeningMing Guo, Abha Khanna, Jianping Wang, et al.Pageof 118